CHI Advisors LLC
- SEC CIK
- 0001791468
- Latest filing
- Nov 13, 2023
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by CHI Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q3 2023 holdings
- Shares (Q3 2023)
- 407,633
- Value
- $13.0M
- % of portfolio
- 5.2%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 407,633 | $13.0M | 5.2% | +5,515+1.4% | Added | Holders |
| Q2 2023 | 402,118 | $16.2M | 4.9% | +141,059+54.0% | Added | Holders |
| Q1 2023 | 261,059 | $11.1M | 3.0% | +46,000+21.4% | Added | Holders |
| Q4 2022 | 215,059 | $10.3M | 2.8% | +14,830+7.4% | Added | Holders |
| Q3 2022 | 200,229 | $7.53M | 2.0% | +96,800+93.6% | Added | Holders |
| Q2 2022 | 103,429 | $2.86M | 1.1% | +41,200+66.2% | Added | Holders |
| Q1 2022 | 62,229 | $3.38M | 1.4% | +44,711+255.2% | Added | Holders |
| Q4 2021 | 17,518 | $1.02M | 0.3% | +4,891+38.7% | Added | Holders |
| Q3 2021 | 12,627 | $500.0K | 0.1% | −103,779−89.2% | Reduced | Holders |
| Q2 2021 | 116,406 | $4.94M | 1.2% | −284,062−70.9% | Reduced | Holders |
| Q1 2021 | 400,468 | $24.6M | 4.9% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.